Full Text
Do Drugs Receiving Fda Priority Review Deliver More Qalys Than Drugs Without The Priority Designation?

Abstract

Authors

T. Thorat J.D. Chambers J. Pyo P.J. Neumann

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×